639 related articles for article (PubMed ID: 22875086)
21. C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
Watson A; Pribadi M; Chowdari K; Clifton S; Joel Wood ; Miller BL; Coppola G; Nimgaonkar V
Psychiatry Res; 2016 Jan; 235():200-2. PubMed ID: 26723138
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
23. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
[TBL] [Abstract][Full Text] [Related]
24. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
[TBL] [Abstract][Full Text] [Related]
25. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
26. Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis.
Dobson-Stone C; Luty AA; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field CD; Panegyres PK; Hecker J; Solski JA; Blair IP; Fullerton JM; Halliday GM; Schofield PR; Kwok JB
Acta Neuropathol; 2013 Apr; 125(4):523-33. PubMed ID: 23338750
[TBL] [Abstract][Full Text] [Related]
27. [C9orf72 in Japanese amyotrophic lateral sclerosis (ALS)].
Tomiyama H
Rinsho Shinkeigaku; 2013; 53(11):1074-6. PubMed ID: 24291883
[TBL] [Abstract][Full Text] [Related]
28. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
29. von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.
Yang Y; Halliday GM; Hodges JR; Tan RH
J Alzheimers Dis; 2017; 58(3):701-709. PubMed ID: 28482638
[TBL] [Abstract][Full Text] [Related]
30. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
[TBL] [Abstract][Full Text] [Related]
32. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
33. ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.
Siuda J; Lewicka T; Bujak M; Opala G; Golenia A; Slowik A; van Blitterswijk M; Baker M; Ertekin-Taner N; Wszolek ZK; Rademakers R
Eur Neurol; 2014; 72(1-2):64-71. PubMed ID: 24861139
[TBL] [Abstract][Full Text] [Related]
34. Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort.
Kertesz A; Ang LC; Jesso S; MacKinley J; Baker M; Brown P; Shoesmith C; Rademakers R; Finger EC
Cogn Behav Neurol; 2013 Sep; 26(3):146-54. PubMed ID: 24077574
[TBL] [Abstract][Full Text] [Related]
35. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.
Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382
[TBL] [Abstract][Full Text] [Related]
36. C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection.
Shamim U; Ambawat S; Singh J; Thomas A; Pradeep-Chandra-Reddy C; Suroliya V; Uppilli B; Parveen S; Sharma P; Chanchal S; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Keerthipriya M; Mahajan NP; Reddy N; Thomas PT; Sadasivan A; Warrier M; Seth M; Zahra S; Mathur A; Vibha D; Srivastava AK; Nalini A; Faruq M
Neurobiol Aging; 2020 Apr; 88():156.e1-156.e9. PubMed ID: 32035847
[TBL] [Abstract][Full Text] [Related]
37. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
[TBL] [Abstract][Full Text] [Related]
38. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
[TBL] [Abstract][Full Text] [Related]
39. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.
Suh E; Lee EB; Neal D; Wood EM; Toledo JB; Rennert L; Irwin DJ; McMillan CT; Krock B; Elman LB; McCluskey LF; Grossman M; Xie SX; Trojanowski JQ; Van Deerlin VM
Acta Neuropathol; 2015 Sep; 130(3):363-72. PubMed ID: 26022924
[TBL] [Abstract][Full Text] [Related]
40. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
